<VariationArchive VariationID="536457" VariationName="NM_004562.3(PRKN):c.155del (p.Asn52fs)" VariationType="Deletion" Accession="VCV000536457" Version="24" RecordType="classified" NumberOfSubmissions="10" NumberOfSubmitters="10" DateLastUpdated="2024-07-29" DateCreated="2018-10-10" MostRecentSubmission="2024-06-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="521494" VariationID="536457">
      <GeneList>
        <Gene Symbol="PRKN" FullName="parkin RBR E3 ubiquitin protein ligase" GeneID="5071" HGNC_ID="HGNC:8607" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>6q26</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="161347417" stop="162727766" display_start="161347417" display_stop="162727766" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="161768589" stop="163148833" display_start="161768589" display_stop="163148833" Strand="-" />
          </Location>
          <OMIM>602544</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_004562.3(PRKN):c.155del (p.Asn52fs)</Name>
      <CanonicalSPDI>NC_000006.12:162443325:TT:T</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>6q26</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="162443326" stop="162443326" display_start="162443326" display_stop="162443326" variantLength="1" positionVCF="162443325" referenceAlleleVCF="AT" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="162864358" stop="162864358" display_start="162864358" display_stop="162864358" variantLength="1" positionVCF="162864357" referenceAlleleVCF="AT" alternateAlleleVCF="A" />
      </Location>
      <OtherNameList>
        <Name>PRKN</Name>
      </OtherNameList>
      <ProteinChange>N52fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004562.2" sequenceAccession="NM_004562" sequenceVersion="2" change="c.155del">
            <Expression>NM_004562.2:c.155del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.162864359del" Assembly="GRCh37">
            <Expression>NC_000006.11:g.162864359del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.12" sequenceAccession="NC_000006" sequenceVersion="12" change="g.162443327del" Assembly="GRCh38">
            <Expression>NC_000006.12:g.162443327del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008289.2" sequenceAccession="NG_008289" sequenceVersion="2" change="g.289477del">
            <Expression>NG_008289.2:g.289477del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004562.3" sequenceAccession="NM_004562" sequenceVersion="3" change="c.155del" MANESelect="true">
            <Expression>NM_004562.3:c.155del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004553.2" sequenceAccession="NP_004553" sequenceVersion="2" change="p.Asn52fs">
            <Expression>NP_004553.2:p.Asn52fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_013987.3" sequenceAccession="NM_013987" sequenceVersion="3" change="c.155del">
            <Expression>NM_013987.3:c.155del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_054642.2" sequenceAccession="NP_054642" sequenceVersion="2" change="p.Asn52fs">
            <Expression>NP_054642.2:p.Asn52fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_013988.3" sequenceAccession="NM_013988" sequenceVersion="3" change="c.155del">
            <Expression>NM_013988.3:c.155del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_054643.2" sequenceAccession="NP_054643" sequenceVersion="2" change="p.Asn52fs">
            <Expression>NP_054643.2:p.Asn52fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004562.3" sequenceAccession="NM_004562" sequenceVersion="3" change="c.155delA" MANESelect="true">
            <Expression>NM_004562.3:c.155delA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA4090497" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="602544.0014" DB="OMIM" />
        <XRef Type="rs" ID="754809877" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004562.3(PRKN):c.155del (p.Asn52fs) AND Autosomal recessive juvenile Parkinson disease 2" Accession="RCV000644912" Version="22">
        <ClassifiedConditionList TraitSetID="1942">
          <ClassifiedCondition DB="MedGen" ID="C1868675">Autosomal recessive juvenile Parkinson disease 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-12-20" SubmissionCount="6">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004562.3(PRKN):c.155del (p.Asn52fs) AND not provided" Accession="RCV001034683" Version="16">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-10-19" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004562.3(PRKN):c.155del (p.Asn52fs) AND multiple conditions" Accession="RCV002477430" Version="8">
        <ClassifiedConditionList TraitSetID="81982">
          <ClassifiedCondition DB="MedGen" ID="C1868675">Autosomal recessive juvenile Parkinson disease 2</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0242379">Lung cancer</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0919267">Ovarian neoplasm</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-07-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-20" NumberOfSubmissions="10" NumberOfSubmitters="10" DateCreated="2018-10-10" MostRecentSubmission="2024-06-23">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10072423</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">10824074</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12056932</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12397156</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16769863</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17095157</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18211709</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19636047</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20558392</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22777964</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22956510</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26683220</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27182553</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27206984</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30537300</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31660654</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31695088</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301651</ID>
          <ID Source="BookShelf">NBK1478</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1942" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3274" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Parkin Type of Early-Onset Parkinson Disease</ElementValue>
                <XRef ID="NBK1478" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parkinson disease, juvenile, autosomal recessive</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parkinson disease autosomal recessive, early onset</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Juvenile parkinsonism</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parkinson disease 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parkinsonism, early onset, with diurnal fluctuation</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive juvenile Parkinson disease 2</ElementValue>
                <XRef ID="MONDO:0010820" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parkinson disease, juvenile, type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parkin Type of Juvenile Parkinson Disease</ElementValue>
                <XRef ID="NBK1478" DB="GeneReviews" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PDJ</ElementValue>
                <XRef Type="MIM" ID="600116" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">JP</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PARK2</ElementValue>
                <XRef Type="MIM" ID="600116" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Parkin type of early-onset Parkinson disease (PARK-Parkin) is characterized by the cardinal signs of Parkinson disease (PD): bradykinesia, resting tremor, and rigidity. The median age at onset is 31 years (range: 3-81 years). The disease is slowly progressive: disease duration of more than 50 years has been reported. Clinical findings vary; hyperreflexia is common. Lower-limb dystonia may be a presenting sign and cognitive decline appears to be no more frequent than in the general population. Dyskinesia as a result of treatment with levodopa frequently occurs.</Attribute>
                <XRef ID="NBK1478" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9642" />
                <XRef ID="9642" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301402</ID>
                <ID Source="BookShelf">NBK1223</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301651</ID>
                <ID Source="BookShelf">NBK1478</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS/MDS-ES, 2013">
                <ID Source="PubMed">23279440</ID>
              </Citation>
              <XRef ID="2828" DB="Orphanet" />
              <XRef ID="C1868675" DB="MedGen" />
              <XRef ID="MONDO:0010820" DB="MONDO" />
              <XRef Type="MIM" ID="600116" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="81982" Type="TraitChoice" ContributesToAggregateClassification="true">
            <Trait ID="3274" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Parkin Type of Early-Onset Parkinson Disease</ElementValue>
                <XRef ID="NBK1478" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parkinson disease, juvenile, autosomal recessive</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parkinson disease autosomal recessive, early onset</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Juvenile parkinsonism</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parkinson disease 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parkinsonism, early onset, with diurnal fluctuation</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive juvenile Parkinson disease 2</ElementValue>
                <XRef ID="MONDO:0010820" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parkinson disease, juvenile, type 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Parkin Type of Juvenile Parkinson Disease</ElementValue>
                <XRef ID="NBK1478" DB="GeneReviews" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PDJ</ElementValue>
                <XRef Type="MIM" ID="600116" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">JP</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PARK2</ElementValue>
                <XRef Type="MIM" ID="600116" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Parkin type of early-onset Parkinson disease (PARK-Parkin) is characterized by the cardinal signs of Parkinson disease (PD): bradykinesia, resting tremor, and rigidity. The median age at onset is 31 years (range: 3-81 years). The disease is slowly progressive: disease duration of more than 50 years has been reported. Clinical findings vary; hyperreflexia is common. Lower-limb dystonia may be a presenting sign and cognitive decline appears to be no more frequent than in the general population. Dyskinesia as a result of treatment with levodopa frequently occurs.</Attribute>
                <XRef ID="NBK1478" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9642" />
                <XRef ID="9642" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301402</ID>
                <ID Source="BookShelf">NBK1223</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301651</ID>
                <ID Source="BookShelf">NBK1478</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS/MDS-ES, 2013">
                <ID Source="PubMed">23279440</ID>
              </Citation>
              <XRef ID="2828" DB="Orphanet" />
              <XRef ID="C1868675" DB="MedGen" />
              <XRef ID="MONDO:0010820" DB="MONDO" />
              <XRef Type="MIM" ID="600116" DB="OMIM" />
            </Trait>
            <Trait ID="5713" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Ovarian tumor</ElementValue>
                <XRef ID="HP:0100615" DB="Human Phenotype Ontology" />
                <XRef ID="123843001" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Ovarian neoplasm</ElementValue>
                <XRef ID="HP:0100615" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0021068" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Neoplasm of ovary</ElementValue>
                <XRef ID="123843001" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ovarian Neoplasms</ElementValue>
              </Name>
              <Citation Type="general" Abbrev="NACB, 2008">
                <ID Source="PubMed">19042984</ID>
              </Citation>
              <Citation Type="general" Abbrev="USPSTF, 2012">
                <ID Source="PubMed">22964825</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2013">
                <ID Source="PubMed">23188549</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2021">
                <ID Source="PubMed">33410258</ID>
              </Citation>
              <Citation Type="general" Abbrev="USPSTF, 2018">
                <ID Source="PubMed">29450531</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2023">
                <URL>https://www.nice.org.uk/guidance/cg122</URL>
                <CitationText>UK NICE Clinical guideline (CG122), Ovarian cancer: recognition and initial management, 2023</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NCCN, 2024">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/ovarian.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN GuidelinesÂ®), Ovarian Cancer Including Fallopian Tube Cancer and Primary Peritoneal Cancer, 2024</CitationText>
              </Citation>
              <XRef ID="C0919267" DB="MedGen" />
              <XRef ID="D010051" DB="MeSH" />
              <XRef ID="MONDO:0021068" DB="MONDO" />
              <XRef Type="primary" ID="HP:0100615" DB="Human Phenotype Ontology" />
            </Trait>
            <Trait ID="54641" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Lung cancer, somatic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Lung cancer</ElementValue>
                <XRef ID="MONDO:0008903" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Malignant tumor of lung</ElementValue>
                <XRef ID="363358000" DB="SNOMED CT" />
              </Name>
              <Citation Type="general" Abbrev="CAP/IASLC/AMP, 2018">
                <ID Source="PubMed">29398453</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2023">
                <URL>https://www.nice.org.uk/guidance/ng122</URL>
                <CitationText>UK NICE guideline NG122, Lung cancer: diagnosis and management, 2023</CitationText>
              </Citation>
              <XRef ID="C0242379" DB="MedGen" />
              <XRef ID="MONDO:0008903" DB="MONDO" />
              <XRef Type="MIM" ID="211980" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1791212" SubmissionDate="2019-02-01" DateLastUpdated="2019-05-27" DateCreated="2019-05-27">
        <ClinVarSubmissionID localKey="656493" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000916135" DateUpdated="2019-05-27" DateCreated="2019-05-27" Type="SCV" Version="1" SubmitterName="Illumina Laboratory Services, Illumina" OrgID="504895" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-10-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12056932</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10824074</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22777964</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20558392</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12397156</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10072423</ID>
          </Citation>
          <Comment>The PARK2 c.155delA (p.Asn52MetfsTer29) variant results in a frameshift and is predicted to result in premature termination of the protein. The p.Asn52MetfsTer29 variant, which is also referred to in the literature as c.255delA, was reported in 24 individuals with juvenile Parkinson disease, including ten in a homozygous state, seven in a compound heterozygous state, and seven in a heterozygous state where zygosity is not noted (Abbas et al. 1999; Lucking et al. 2000; Hoenicka et al. 2002; Munoz et al. 2002; Marder et al. 2010; Guerrero Camacho et al. 2012). The p.Asn52MetfsTer29 variant was also found in a heterozygous state in seven unaffected relatives (Hoenicka et al. 2002). The p.Asn52MetfsTer29 variant was reported in two of 283 controls and is reported at a frequency of 0.001123 in the Latino population of the Exome Aggregation Consortium. Due to the presence of this variant in a large number of cases, and the potential functional impact of frameshift variants, the p.Asn52MetfsTer29 variant is classified as pathogenic for juvenile Parkinson disease. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSL Variant Classification Criteria 09 May 2019</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/thsgk7t4/icsl_variant_classification_criteria_09_may_2019.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PARK2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="6" alternateAllele="A" referenceAllele="AT" start="162864357" stop="162864358" variantLength="2" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004562.2:c.155delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="600116" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5118208</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3003444" SubmissionDate="2021-03-05" DateLastUpdated="2021-03-22" DateCreated="2021-03-22">
        <ClinVarSubmissionID localKey="NM_004562.2:c.155delA|OMIM:600116" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001528229" DateUpdated="2021-03-22" DateCreated="2021-03-22" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-11-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868].</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRKN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004562.2:c.155delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="600116" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB9201740</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4033188" SubmissionDate="2021-12-21" DateLastUpdated="2022-01-08" DateCreated="2022-01-08">
        <ClinVarSubmissionID localKey="NM_004562.2:c.155del|OMIM:600116" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002059552" DateUpdated="2022-01-08" DateCreated="2022-01-08" Type="SCV" Version="1" SubmitterName="Centogene AG  - the Rare Disease Company" OrgID="279559" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-07-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRKN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004562.2:c.155del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="600116" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10812468</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4894039" SubmissionDate="2022-04-22" DateLastUpdated="2022-04-23" DateCreated="2022-04-23">
        <ClinVarSubmissionID localKey=":Chr.6_162864357_AT_A|Not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002502195" DateUpdated="2022-04-23" DateCreated="2022-04-23" Type="SCV" Version="1" SubmitterName="AiLife Diagnostics, AiLife Diagnostics" OrgID="507594" OrganizationCategory="laboratory" OrgAbbreviation="AiLife" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10072423</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12397156</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31660654</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17095157</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27206984</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26683220</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31695088</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16769863</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18211709</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30537300</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <TypePlatform>NGS</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SecondaryFinding">no</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRKN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="6" alternateAllele="A" referenceAllele="AT" start="162864357" stop="162864358" variantLength="2" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11350707</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5002323" SubmissionDate="2022-12-11" DateLastUpdated="2022-12-17" DateCreated="2022-08-04">
        <ClinVarSubmissionID localKey="sa_pathology/molecular_pathology_fmc/vc15848" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002556369" DateUpdated="2022-12-17" DateCreated="2022-08-04" Type="SCV" Version="2" SubmitterName="Genetics and Molecular Pathology, SA Pathology" OrgID="506043" OrganizationCategory="laboratory" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-06-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRKN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_12260</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004562.2:c.155delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="600116" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_33</SubmissionName>
          <SubmissionName>submission_36</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2905137" SubmissionDate="2022-12-27" DateLastUpdated="2022-12-31" DateCreated="2021-01-26">
        <ClinVarSubmissionID localKey="A11840|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001475991" DateUpdated="2022-12-31" DateCreated="2021-01-26" Type="SCV" Version="2" SubmitterName="Athena Diagnostics" OrgID="1012" OrganizationCategory="laboratory" OrgAbbreviation="ADX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-11-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10072423</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17095157</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27206984</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26683220</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30537300</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22777964</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20558392</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18211709</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16769863</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12397156</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12056932</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10824074</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27182553</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19636047</ID>
          </Citation>
          <Comment>This variant is expected to result in the loss of a functional protein. The frequency of this variant in the general population is consistent with pathogenicity (http://gnomad.broadinstitute.org). This variant has been identified in at least one individual with clinical features associated with this gene. In multiple individuals, this variant has been seen where an alternate explanation for disease was also identified, suggesting this variant is unlikely to cause disease.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Athena Diagnostics Criteria</Attribute>
          <Citation>
            <ID Source="PubMed">26467025</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004562.2:c.155del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12478070</SubmissionName>
          <SubmissionName>SUB8819545</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="27664" SubmissionDate="2013-05-14" DateLastUpdated="2022-12-31" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="602544.0014_PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE" title="PRKN, 1-BP DEL, 255A_PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE" />
        <ClinVarAccession Accession="SCV000027664" DateUpdated="2022-12-31" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2002-06-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 2 Spanish families, Hoenicka et al. (2002) found deletion of 1 adenine at nucleotide 202 of the PARK2 gene in members with juvenile Parkinson disease (600116). The mutation was homozygous in 1 family and compound heterozygous with a deletion of exons 8 and 9 (602544.0006) in the other. In the first family, there was 1 individual who was a heterozygous carrier of only the 255delA mutation who developed transient drug-induced parkinsonism at 45 years of age while being treated with haloperidol.</Attribute>
              <Citation>
                <ID Source="PubMed">12056932</ID>
              </Citation>
              <XRef DB="OMIM" ID="600116" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">The 255delA mutation in PARK2 was originally described by Abbas et al. (1999).</Attribute>
              <Citation>
                <ID Source="PubMed">10072423</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRKN" />
          </GeneList>
          <Name>PRKN, 1-BP DEL, 255A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 255A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="602544.0014" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3255233" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2021-05-28">
        <ClinVarSubmissionID localKey="NM_004562.2:c.155del|OMIM:167000;211980;600116" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001652818" DateUpdated="2022-12-31" DateCreated="2021-05-28" Type="SCV" Version="2" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-07-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004562.2:c.155del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="167000" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="211980" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="600116" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
          <SubmissionName>SUB9694437</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7829829" SubmissionDate="2023-12-22" DateLastUpdated="2024-06-23" DateCreated="2024-06-23">
        <ClinVarSubmissionID localKey="SUB14101522" submittedAssembly="GRCh38" title="SUB14101522" />
        <ClinVarAccession Accession="SCV004177279" DateUpdated="2024-06-23" DateCreated="2024-06-23" Type="SCV" Version="1" SubmitterName="Human Genetics Laboratory, State University of Rio de Janeiro" OrgID="506955" OrganizationCategory="laboratory" OrgAbbreviation="SERVGEN" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Ethnicity>mixed</Ethnicity>
              <GeographicOrigin>Brazil</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">50</Age>
              <Age Type="maximum" age_unit="years">59</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PARK2">
              <Name>parkin RBR E3 ubiquitin protein ligase</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_004562.3:exon 2</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>PRKN</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="dbSNP" ID="rs754809877" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004562.3:c.155delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="600116" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14101522</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1476381" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2018-05-28">
        <ClinVarSubmissionID localKey="304522|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000766632" DateUpdated="2024-02-14" DateCreated="2018-05-28" Type="SCV" Version="8" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10072423</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20301651</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22956510</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10072423</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16769863</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18211709</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27206984</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30537300</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Asn52Metfs*29) in the PRKN gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PRKN are known to be pathogenic (PMID: 10072423, 20301651, 22956510). This variant is present in population databases (rs754809877, gnomAD 0.1%). This premature translational stop signal has been observed in individuals with Parkinson disease (PMID: 10072423, 16769863, 18211709, 27206984, 30537300). It has also been observed to segregate with disease in related individuals. This variant is also known as 255delA, c.154delA, N52fsX80, Asn52/Stop81, and N52/STOP80. ClinVar contains an entry for this variant (Variation ID: 536457). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PRKN" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000006.11:g.162864358del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="27664" TraitType="Disease" MappingType="Name" MappingValue="PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE" MappingRef="Preferred">
        <MedGen CUI="C1868675" Name="Autosomal recessive juvenile Parkinson disease 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4894039" TraitType="Disease" MappingType="Name" MappingValue="Not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7829829" TraitType="Disease" MappingType="XRef" MappingValue="600116" MappingRef="OMIM">
        <MedGen CUI="C1868675" Name="Autosomal recessive juvenile Parkinson disease 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3255233" TraitType="Disease" MappingType="XRef" MappingValue="167000" MappingRef="OMIM">
        <MedGen CUI="C1140680" Name="Ovarian cancer" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4033188" TraitType="Disease" MappingType="XRef" MappingValue="600116" MappingRef="OMIM">
        <MedGen CUI="C1868675" Name="Autosomal recessive juvenile Parkinson disease 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5002323" TraitType="Disease" MappingType="XRef" MappingValue="600116" MappingRef="OMIM">
        <MedGen CUI="C1868675" Name="Autosomal recessive juvenile Parkinson disease 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1476381" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3255233" TraitType="Disease" MappingType="XRef" MappingValue="211980" MappingRef="OMIM">
        <MedGen CUI="C0242379" Name="Lung cancer" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1791212" TraitType="Disease" MappingType="XRef" MappingValue="600116" MappingRef="OMIM">
        <MedGen CUI="C1868675" Name="Autosomal recessive juvenile Parkinson disease 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2905137" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3255233" TraitType="Disease" MappingType="XRef" MappingValue="600116" MappingRef="OMIM">
        <MedGen CUI="C1868675" Name="Autosomal recessive juvenile Parkinson disease 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3003444" TraitType="Disease" MappingType="XRef" MappingValue="600116" MappingRef="OMIM">
        <MedGen CUI="C1868675" Name="Autosomal recessive juvenile Parkinson disease 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

